Package 11673-819-08

{"route": ["ORAL"], "spl_id": "46536f85-5a10-9ebe-e063-6394a90a97bd", "openfda": {"unii": ["TC2D6JAD40", "9TN87S3A3C"], "rxcui": ["1550957"], "spl_set_id": ["fe82699d-fdc2-038e-e053-6294a90a606c"], "manufacturer_name": ["TARGET CORPORATION"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "80 TABLET in 1 BOTTLE (11673-819-08)", "package_ndc": "11673-819-08", "marketing_start_date": "20240301"}], "brand_name": "Naproxen Sodium and Diphenhydramine HCL", "product_id": "11673-819_46536f85-5a10-9ebe-e063-6394a90a97bd", "dosage_form": "TABLET", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "11673-819", "generic_name": "Naproxen Sodium and Diphenhydramine HCL", "labeler_name": "TARGET CORPORATION", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Naproxen Sodium and Diphenhydramine HCL", "active_ingredients": [{"name": "DIPHENHYDRAMINE HYDROCHLORIDE", "strength": "25 mg/1"}, {"name": "NAPROXEN SODIUM", "strength": "220 mg/1"}], "application_number": "ANDA213663", "marketing_category": "ANDA", "marketing_start_date": "20240301", "listing_expiration_date": "20261231"}